• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

后期促进复合物/细胞周期体的致癌调节因子和底物在恶性肿瘤中经常过度表达。

Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.

作者信息

Lehman Norman L, Tibshirani Rob, Hsu Jerry Y, Natkunam Yasodha, Harris Brent T, West Robert B, Masek Marilyn A, Montgomery Kelli, van de Rijn Matt, Jackson Peter K

机构信息

Department of Pathology, MC5324, Stanford University, Stanford, CA, USA.

出版信息

Am J Pathol. 2007 May;170(5):1793-805. doi: 10.2353/ajpath.2007.060767.

DOI:10.2353/ajpath.2007.060767
PMID:17456782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1854971/
Abstract

The fidelity of cell division is dependent on the accumulation and ordered destruction of critical protein regulators. By triggering the appropriately timed, ubiquitin-dependent proteolysis of the mitotic regulatory proteins securin, cyclin B, aurora A kinase, and polo-like kinase 1, the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase plays an essential role in maintaining genomic stability. Misexpression of these APC/C substrates, individually, has been implicated in genomic instability and cancer. However, no comprehensive survey of the extent of their misregulation in tumors has been performed. Here, we analyzed more than 1600 benign and malignant tumors by immunohistochemical staining of tissue microarrays and found frequent overexpression of securin, polo-like kinase 1, aurora A, and Skp2 in malignant tumors. Positive and negative APC/C regulators, Cdh1 and Emi1, respectively, were also more strongly expressed in malignant versus benign tumors. Clustering and statistical analysis supports the finding that malignant tumors generally show broad misregulation of mitotic APC/C substrates not seen in benign tumors, suggesting that a "mitotic profile" in tumors may result from misregulation of the APC/C destruction pathway. This profile of misregulated mitotic APC/C substrates and regulators in malignant tumors suggests that analysis of this pathway may be diagnostically useful and represent a potentially important therapeutic target.

摘要

细胞分裂的保真度取决于关键蛋白质调节因子的积累和有序破坏。后期促进复合物/细胞周期体(APC/C)泛素连接酶通过触发有丝分裂调节蛋白securin、细胞周期蛋白B、极光激酶A和polo样激酶1适时的、泛素依赖性蛋白水解,在维持基因组稳定性方面发挥着重要作用。这些APC/C底物中的任何一种表达异常都与基因组不稳定和癌症有关。然而,尚未对它们在肿瘤中失调的程度进行全面调查。在这里,我们通过组织微阵列的免疫组织化学染色分析了1600多个良性和恶性肿瘤,发现securin、polo样激酶1、极光激酶A和Skp2在恶性肿瘤中频繁过表达。APC/C的正负调节因子Cdh1和Emi1在恶性肿瘤中的表达也分别比良性肿瘤中更强。聚类和统计分析支持了这一发现,即恶性肿瘤通常表现出有丝分裂APC/C底物的广泛失调,而良性肿瘤中未见这种情况,这表明肿瘤中的“有丝分裂谱”可能是由于APC/C破坏途径失调所致。恶性肿瘤中有丝分裂APC/C底物和调节因子的这种失调情况表明,对该途径的分析可能具有诊断价值,并代表一个潜在的重要治疗靶点。

相似文献

1
Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors.后期促进复合物/细胞周期体的致癌调节因子和底物在恶性肿瘤中经常过度表达。
Am J Pathol. 2007 May;170(5):1793-805. doi: 10.2353/ajpath.2007.060767.
2
Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).早有研究表明,细胞分裂抑制剂-1(一种促进有丝分裂复合物/周期蛋白体抑制剂)可抑制肝癌细胞增殖:这与 Skp2 的稳定性以及 p27(Kip1)的降解相关。
Hum Pathol. 2013 Mar;44(3):365-73. doi: 10.1016/j.humpath.2012.03.030. Epub 2012 Sep 17.
3
The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells.泛素连接酶APC(Cdh1)是维持原代人类细胞基因组完整性所必需的。
Oncogene. 2008 Feb 7;27(7):907-17. doi: 10.1038/sj.onc.1210703. Epub 2007 Aug 13.
4
The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1.致癌基因evi5通过稳定后期促进复合体抑制剂emi1来调控细胞周期蛋白的积累。
Cell. 2006 Jan 27;124(2):367-80. doi: 10.1016/j.cell.2005.10.038.
5
APC/C Cdh1 targets aurora kinase to control reorganization of the mitotic spindle at anaphase.后期促进复合物/细胞周期蛋白水解酶1(APC/C Cdh1)靶向极光激酶,以控制后期有丝分裂纺锤体的重组。
Curr Biol. 2008 Nov 11;18(21):1649-58. doi: 10.1016/j.cub.2008.09.058. Epub 2008 Oct 30.
6
Destruction box-dependent degradation of aurora B is mediated by the anaphase-promoting complex/cyclosome and Cdh1.依赖于破坏盒的极光B降解由后期促进复合物/细胞周期体和Cdh1介导。
Cancer Res. 2005 Oct 1;65(19):8730-5. doi: 10.1158/0008-5472.CAN-05-1500.
7
Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.Plk1通过磷酸化并触发SCFβTrCP依赖的后期促进复合体抑制因子Emi1的降解来调控后期促进复合体的激活。
Mol Biol Cell. 2004 Dec;15(12):5623-34. doi: 10.1091/mbc.e04-07-0598. Epub 2004 Oct 6.
8
Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.Polo样激酶1:后期促进复合物/细胞周期体依赖性蛋白水解的靶点与调节因子
Cancer Res. 2006 Jul 15;66(14):6895-8. doi: 10.1158/0008-5472.CAN-06-0358.
9
Polo-like kinase-1 controls Aurora A destruction by activating APC/C-Cdh1.Polo样激酶-1通过激活后期促进复合物/细胞周期蛋白依赖性蛋白水解酶1来控制极光激酶A的降解。
PLoS One. 2009;4(4):e5282. doi: 10.1371/journal.pone.0005282. Epub 2009 Apr 23.
10
Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.Emi1作为一种假底物抑制剂稳定结合并抑制后期促进复合物/细胞周期体。
Genes Dev. 2006 Sep 1;20(17):2410-20. doi: 10.1101/gad.1454006. Epub 2006 Aug 18.

引用本文的文献

1
METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer.METTL16通过m6A修饰调节FBXO5的mRNA稳定性,以促进乳腺癌的恶性行为。
Cancer Metab. 2024 Jul 25;12(1):22. doi: 10.1186/s40170-024-00351-5.
2
Downregulation of Splicing Factor Curtails Expression to Promote Cellular Senescence in Lung Adenocarcinoma.剪接因子的下调减少表达以促进肺腺癌中的细胞衰老。
Curr Issues Mol Biol. 2024 Jul 19;46(7):7730-7744. doi: 10.3390/cimb46070458.
3
G1 Dynamics at the Crossroads of Pluripotency and Cancer.多能性与癌症交叉点上的G1动力学
Cancers (Basel). 2023 Sep 14;15(18):4559. doi: 10.3390/cancers15184559.
4
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma.后期促进复合体的激活可逆转犬多药耐药淋巴瘤模型中的多药耐药癌症。
Cancers (Basel). 2022 Aug 30;14(17):4215. doi: 10.3390/cancers14174215.
5
Combined Transcriptomic and Proteomic Profiling to Unravel Osimertinib, CARP-1 Functional Mimetic (CFM 4.17) Formulation and Telmisartan Combo Treatment in NSCLC Tumor Xenografts.联合转录组学和蛋白质组学分析以揭示奥希替尼、CARP-1功能模拟物(CFM 4.17)制剂与替米沙坦联合治疗非小细胞肺癌肿瘤异种移植的效果
Pharmaceutics. 2022 May 28;14(6):1156. doi: 10.3390/pharmaceutics14061156.
6
Examining the mechanistic relationship of APC/C and its interphase inhibitor EMI1.研究 APC/C 及其间隙期抑制剂 EMI1 的机制关系。
Protein Sci. 2022 Jun;31(6):e4324. doi: 10.1002/pro.4324.
7
The role of Fbxo5 in the development of human malignant tumors.Fbxo5在人类恶性肿瘤发生发展中的作用。
Am J Cancer Res. 2022 Apr 15;12(4):1456-1464. eCollection 2022.
8
Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms.极光激酶-A 在正常 Müller 上皮和良性、交界性和恶性浆液性卵巢肿瘤中存在于细胞核和细胞质中的表达存在差异。
Diagn Pathol. 2021 Oct 27;16(1):98. doi: 10.1186/s13000-021-01158-4.
9
Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer.替米沙坦促进 CARP-1 功能模拟物和索拉非尼在 Rociletinib 耐药非小细胞肺癌中的抗癌作用。
Anticancer Res. 2021 Sep;41(9):4215-4228. doi: 10.21873/anticanres.15226. Epub 2021 Sep 1.
10
The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.SCF 复合物对于维持基因组和染色体稳定性至关重要。
Int J Mol Sci. 2021 Aug 9;22(16):8544. doi: 10.3390/ijms22168544.

本文引用的文献

1
Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.Emi1作为一种假底物抑制剂稳定结合并抑制后期促进复合物/细胞周期体。
Genes Dev. 2006 Sep 1;20(17):2410-20. doi: 10.1101/gad.1454006. Epub 2006 Aug 18.
2
Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells.后期促进复合体/细胞周期体抑制剂Emi1的过表达导致p53缺陷细胞的四倍体化和基因组不稳定。
Cell Cycle. 2006 Jul;5(14):1569-73. doi: 10.4161/cc.5.14.2925. Epub 2006 Jul 17.
3
Screening of tissue microarrays for ubiquitin proteasome system components in tumors.肿瘤中泛素蛋白酶体系统成分的组织微阵列筛选
Methods Enzymol. 2005;399:334-55. doi: 10.1016/S0076-6879(05)99023-X.
4
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.胞质分裂失败产生四倍体促进p53基因缺失细胞的肿瘤发生。
Nature. 2005 Oct 13;437(7061):1043-7. doi: 10.1038/nature04217.
5
Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines.在人类细胞系中,染色体不分离产生的是四倍体细胞而非非整倍体细胞。
Nature. 2005 Oct 13;437(7061):1038-42. doi: 10.1038/nature03958.
6
Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.Ras 关联结构域家族 1 肿瘤抑制基因在人类癌症中的作用。
Cancer Res. 2005 May 1;65(9):3497-508. doi: 10.1158/0008-5472.CAN-04-4088.
7
Getting in and out of mitosis with Polo-like kinase-1.通过Polo样激酶-1进出有丝分裂
Oncogene. 2005 Apr 18;24(17):2844-59. doi: 10.1038/sj.onc.1208617.
8
How do so few control so many?为何如此少的人能控制如此多的人?
Cell. 2005 Mar 25;120(6):739-46. doi: 10.1016/j.cell.2005.03.006.
9
Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.乳腺癌中的Polo样激酶亚型:表达模式及预后意义
Virchows Arch. 2005 Apr;446(4):442-50. doi: 10.1007/s00428-005-1212-8. Epub 2005 Mar 23.
10
Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships.乳腺癌浸润性导管癌中后期促进复合物(APC)7的下调及其临床病理关系。
Breast Cancer Res. 2005;7(2):R238-47. doi: 10.1186/bcr978. Epub 2005 Jan 14.